Halozyme Therapeutics
HALO
#2184
Rank
C$10.33 B
Marketcap
$81.26
Share price
1.06%
Change (1 day)
76.09%
Change (1 year)

Halozyme Therapeutics (HALO) Fails to deliver data

Key failure to deliver metrics for Halozyme Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Halozyme Therapeutics (HALO) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Halozyme Therapeutics (HALO) - since 2013

Volume in USD (price x number of shares), data since 2013

Halozyme Therapeutics (HALO) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025C$3.21 M-86.56%
2024C$23.89 M-6.29%
2023C$25.5 M-15.59%
2022C$30.2 M38.39%
2021C$21.82 M-6.23%
2020C$23.27 M-44.23%
2019C$41.74 M591.9%
2018C$6.03 M-64.48%
2017C$16.98 M-5.65%
2016C$17.99 M-13.05%
2015C$20.7 M-7.81%
2014C$22.45 M140.61%
2013C$9.33 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
C$0.15 MC$13.31 M๐Ÿ‡บ๐Ÿ‡ธ USA
C$76.39 MC$0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA
C$8.1 MC$38.92 M๐Ÿ‡บ๐Ÿ‡ธ USA
C$28.68 MC$0.33 B๐Ÿ‡บ๐Ÿ‡ธ USA
C$4.02 MC$72.89 M๐Ÿ‡ซ๐Ÿ‡ท France
C$21.76 MC$0.31 B๐Ÿ‡บ๐Ÿ‡ธ USA